首页 > 最新文献

Videosurgery and Other Miniinvasive Techniques最新文献

英文 中文
Outcomes of a newly established bariatric program in a hospital without an intensive care unit: a retrospective analysis of safety and effectiveness. 在没有重症监护病房的医院新建立的减肥计划的结果:安全性和有效性的回顾性分析。
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-08-05 eCollection Date: 2025-10-06 DOI: 10.20452/wiitm.2025.17975
Przemysław Sroczyński, Krzysztof Jędras, Grzegorz Dobkowski, Agata Gaździńska, Dariusz Tomaszewski, Robert Drozdowski, Michał Janik

Introduction: Bariatric surgery effectively contributes to substantial weight loss and improvement of obesity‑related comorbidities. Establishing new bariatric programs, particularly in hospitals without intensive care units, requires tailored implementation strategies and careful resource planning to ensure both safety and efficacy.

Aim: The aim of this study was to retrospectively assess the safety and efficacy outcomes of a newly implemented bariatric program the Military Institute of Aviation Medicine.

Materials and methods: This retrospective study evaluated all bariatric surgeries (n = 267) performed between September 2021 and December 2024 at our hospital following the establishment of a comprehensive bariatric program. The program included surgeon training, multidisciplinary team formation, protocol development, and infrastructure modifications. Patient demographics, operative details, complications, weight loss outcomes, and resolution of comorbidities were analyzed.

Result: Laparoscopic sleeve gastrectomy (LSG) was the predominant procedure (85.77%), followed by laparoscopic Roux‑en‑Y gastric bypass (LRYGB, 13.86%). Mean (SD) operative time was 145 (35) minutes for LRYGB and 77 (19) minutes for LSG. Overall, 93.1% of the patients had no complications, with the rate of serious complications requiring surgical intervention (Clavien-Dindo grade IIIB) decreasing from 7.69% in 2021 to 0.97% in 2024. No mortalities occurred. Among the 112 patients (68.3%) with available follow‑up data, mean (SD) percentage of total weight loss was 29.61% (12.08%) for LRYGB and 25.92% (10.57%) for LSG. High rates of comorbidity resolution were observed for type 2 diabetes mellitus (90.91%), hypertension (65.79%), dyslipidemia (70%), and metabolic syndrome (91.67%).

Conclusion: With careful planning, comprehensive team training, and adherence to established protocols, a new bariatric surgery program can achieve excellent safety and effectiveness outcomes from inception. The results validate our approach to program development and patient care.

前言:减肥手术有效地减轻了体重,改善了肥胖相关的合并症。建立新的减肥计划,特别是在没有重症监护病房的医院,需要有针对性的实施战略和仔细的资源规划,以确保安全性和有效性。目的:本研究的目的是回顾性评估军事航空医学研究所新实施的减肥计划的安全性和有效性结果。材料和方法:本回顾性研究评估了2021年9月至2024年12月在我院建立综合减肥计划后进行的所有减肥手术(n = 267)。该项目包括外科医生培训、多学科团队组建、协议制定和基础设施改造。分析患者人口统计学、手术细节、并发症、减肥结果和合并症的解决。结果:腹腔镜袖胃切除术(LSG)占85.77%,其次为腹腔镜Roux - en - Y胃旁路术(LRYGB),占13.86%。LRYGB的平均(SD)手术时间为145(35)分钟,LSG的平均(SD)时间为77(19)分钟。总体而言,93.1%的患者无并发症,需要手术干预的严重并发症发生率(Clavien-Dindo分级IIIB)从2021年的7.69%下降到2024年的0.97%。无死亡发生。在有随访数据的112例患者(68.3%)中,LRYGB组总体重减轻的平均(SD)百分比为29.61% (12.08%),LSG组为25.92%(10.57%)。2型糖尿病(90.91%)、高血压(65.79%)、血脂异常(70%)和代谢综合征(91.67%)的合并症缓解率较高。结论:通过周密的计划,全面的团队培训,并遵守既定的方案,一个新的减肥手术方案可以从一开始就获得良好的安全性和有效性。结果验证了我们在项目开发和患者护理方面的方法。
{"title":"Outcomes of a newly established bariatric program in a hospital without an intensive care unit: a retrospective analysis of safety and effectiveness.","authors":"Przemysław Sroczyński, Krzysztof Jędras, Grzegorz Dobkowski, Agata Gaździńska, Dariusz Tomaszewski, Robert Drozdowski, Michał Janik","doi":"10.20452/wiitm.2025.17975","DOIUrl":"10.20452/wiitm.2025.17975","url":null,"abstract":"<p><strong>Introduction: </strong>Bariatric surgery effectively contributes to substantial weight loss and improvement of obesity‑related comorbidities. Establishing new bariatric programs, particularly in hospitals without intensive care units, requires tailored implementation strategies and careful resource planning to ensure both safety and efficacy.</p><p><strong>Aim: </strong>The aim of this study was to retrospectively assess the safety and efficacy outcomes of a newly implemented bariatric program the Military Institute of Aviation Medicine.</p><p><strong>Materials and methods: </strong>This retrospective study evaluated all bariatric surgeries (n = 267) performed between September 2021 and December 2024 at our hospital following the establishment of a comprehensive bariatric program. The program included surgeon training, multidisciplinary team formation, protocol development, and infrastructure modifications. Patient demographics, operative details, complications, weight loss outcomes, and resolution of comorbidities were analyzed.</p><p><strong>Result: </strong>Laparoscopic sleeve gastrectomy (LSG) was the predominant procedure (85.77%), followed by laparoscopic Roux‑en‑Y gastric bypass (LRYGB, 13.86%). Mean (SD) operative time was 145 (35) minutes for LRYGB and 77 (19) minutes for LSG. Overall, 93.1% of the patients had no complications, with the rate of serious complications requiring surgical intervention (Clavien-Dindo grade IIIB) decreasing from 7.69% in 2021 to 0.97% in 2024. No mortalities occurred. Among the 112 patients (68.3%) with available follow‑up data, mean (SD) percentage of total weight loss was 29.61% (12.08%) for LRYGB and 25.92% (10.57%) for LSG. High rates of comorbidity resolution were observed for type 2 diabetes mellitus (90.91%), hypertension (65.79%), dyslipidemia (70%), and metabolic syndrome (91.67%).</p><p><strong>Conclusion: </strong>With careful planning, comprehensive team training, and adherence to established protocols, a new bariatric surgery program can achieve excellent safety and effectiveness outcomes from inception. The results validate our approach to program development and patient care.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 3","pages":"279-284"},"PeriodicalIF":1.9,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12590360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of combining transcervical fibroid ablation with operative hysteroscopy. 经宫颈肌瘤消融联合手术宫腔镜治疗的安全性和有效性。
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-08-05 eCollection Date: 2025-10-06 DOI: 10.20452/wiitm.2025.17974
Elvin Piriyev, Angelika Dieter, Sven Schiermeier, Stefan Renner, Thomas Römer

Introduction: Minimally-invasive, organ-preserving techniques for uterine fibroid management have gained popularity. This study assesses the safety and effectiveness of combining transcervical fibroid ablation (TFA) with operative hysteroscopy (HSC).

Aim: We aimed to evaluate whether a combined approach that involves performing TFA and operative HSC during a single session increased the intra- and postoperative risks.

Materials and methods: A total of 200 women were included in this retrospective study. They were divided into 2 groups: 100 underwent combined TFA and operative HSC (group 1), and 100 underwent HSC alone (group 2). Surgical procedures included fibroid / polyp resection, endometrial ablation, and septum dissection. Outcomes assessed comprised intra- and postoperative complications and symptom improvement.

Result: Complication rates were low and comparable in both groups. Among the patients in group 1 with available follow-up (n = 60), 83.3% reported improvement in bleeding symptoms, particularly those treated with TFA combined with myomectomy (84%). The combined approach enabled treatment of a broader range of fibroid types (International Federation of Gynecology and Obstetrics score 0-6) and intrauterine pathologies in a single session. No severe or life-threatening complications were observed. The risk of bleeding during fibroid resection was reduced when the resection was preceded by TFA (P = 0.001).

Conclusion: Combining TFA and HSC appears to be a safe, effective, and versatile approach for treating uterine fibroids and intrauterine pathologies. It offers procedural efficiency, broadens treatment eligibility, and may reduce the need for reintervention.

微创、器官保存技术在子宫肌瘤治疗中的应用越来越广泛。本研究评估经宫颈肌瘤消融(TFA)联合手术宫腔镜(HSC)的安全性和有效性。目的:我们的目的是评估在一次手术中进行TFA和手术HSC的联合方法是否会增加手术内和术后风险。材料与方法:回顾性研究共纳入200名女性。患者分为两组:100例行TFA联合手术HSC(1组),100例单独行HSC(2组)。手术包括肌瘤/息肉切除、子宫内膜消融和隔膜剥离。结果评估包括手术内和术后并发症和症状改善。结果:两组并发症发生率均较低,具有可比性。在可随访的第1组患者中(n = 60), 83.3%的患者报告出血症状有所改善,特别是TFA联合子宫肌瘤切除术的患者(84%)。联合方法可以在一次治疗中治疗更广泛的子宫肌瘤类型(国际妇产科联合会评分0-6)和子宫内病变。未见严重或危及生命的并发症。在肌瘤切除术前行TFA可降低子宫肌瘤切除术时出血的风险(P = 0.001)。结论:TFA联合HSC是治疗子宫肌瘤和宫内病变的一种安全、有效、通用的方法。它提高了程序效率,扩大了治疗资格,并可能减少再干预的需要。
{"title":"Safety and efficacy of combining transcervical fibroid ablation with operative hysteroscopy.","authors":"Elvin Piriyev, Angelika Dieter, Sven Schiermeier, Stefan Renner, Thomas Römer","doi":"10.20452/wiitm.2025.17974","DOIUrl":"10.20452/wiitm.2025.17974","url":null,"abstract":"<p><strong>Introduction: </strong>Minimally-invasive, organ-preserving techniques for uterine fibroid management have gained popularity. This study assesses the safety and effectiveness of combining transcervical fibroid ablation (TFA) with operative hysteroscopy (HSC).</p><p><strong>Aim: </strong>We aimed to evaluate whether a combined approach that involves performing TFA and operative HSC during a single session increased the intra- and postoperative risks.</p><p><strong>Materials and methods: </strong>A total of 200 women were included in this retrospective study. They were divided into 2 groups: 100 underwent combined TFA and operative HSC (group 1), and 100 underwent HSC alone (group 2). Surgical procedures included fibroid / polyp resection, endometrial ablation, and septum dissection. Outcomes assessed comprised intra- and postoperative complications and symptom improvement.</p><p><strong>Result: </strong>Complication rates were low and comparable in both groups. Among the patients in group 1 with available follow-up (n = 60), 83.3% reported improvement in bleeding symptoms, particularly those treated with TFA combined with myomectomy (84%). The combined approach enabled treatment of a broader range of fibroid types (International Federation of Gynecology and Obstetrics score 0-6) and intrauterine pathologies in a single session. No severe or life-threatening complications were observed. The risk of bleeding during fibroid resection was reduced when the resection was preceded by TFA (<i>P</i> = 0.001).</p><p><strong>Conclusion: </strong>Combining TFA and HSC appears to be a safe, effective, and versatile approach for treating uterine fibroids and intrauterine pathologies. It offers procedural efficiency, broadens treatment eligibility, and may reduce the need for reintervention.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 3","pages":"302-309"},"PeriodicalIF":1.9,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12590361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and prediction model for stone mucosa adhesion before retrograde intrarenal surgery. 逆行肾内手术前结石粘膜粘连的危险因素及预测模型。
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-24 eCollection Date: 2025-10-06 DOI: 10.20452/wiitm.2025.17973
Hongliang Wei, Xiaowei Wang, Shuo Zheng, Zhong Li, Lei Wang, Wei Li

Introduction: Preoperative assessment of ureteral adhesions related to stones is crucial for choosing the right surgical approach.

Aim: This study aimed to evaluate clinically significant factors for predicting the development of adhesions between the calculus and the mucosa in patients with ureteral stones undergoing retrograde intrarenal surgery.

Materials and methods: The study included 173 patients. Ureteroscopy was performed to accurately identify the presence of adhesions between the calculus and the mucosa. Univariate and multivariable logistic regression analyses were performed to identify independent factors predicting adhesions. An alignment diagram model was developed utilizing the independent factors identified. Discrimination and calibration of the model were evaluated via the receiver operating characteristic curve and further examined via calibration curves, decision curve analysis, and cumulative intervention curves.

Result: Adhesions between the calculus and the mucosa were confirmed on ureteroscopy in 48 patients (27.7%). Multivariable logistic regression analyses showed that ureteral wall thickness (UWT), hydronephrosis severity, perirenal fat stranding (PFS), and pain intensity were independent risk predictors of adhesions (P <⁠0.001; P <⁠0.001; P = 0.02; P = 0.02, respectively). The estimated area under the curve in the group with and without adhesions was 0.849 (95% CI, 0.742-0.832) and 0.888 (95% CI, 0.829-0.833), respectively, demonstrating an excellent predictive performance of the model.

Conclusion: UWT, PFS, hydronephrosis severity, and pain intensity are independent risk factors for the development of adhesions between the calculus and the mucosa. Our predictive model exhibited outstanding performance, and it may help clinicians choose the most appropriate surgical method.

导读:术前评估输尿管结石粘连对选择正确的手术入路至关重要。目的:本研究旨在评估输尿管结石行逆行肾内手术患者结石与粘膜粘连发生的临床重要因素。材料与方法:纳入173例患者。进行输尿管镜检查以准确识别结石与粘膜之间粘连的存在。采用单变量和多变量logistic回归分析确定预测粘连的独立因素。利用识别出的独立因素,建立了对齐图模型。通过受试者工作特征曲线评估模型的判别和校准,并进一步通过校准曲线、决策曲线分析和累积干预曲线进行检验。结果:输尿管镜检查结石与粘膜粘连48例(27.7%)。多变量logistic回归分析显示,输尿管壁厚度(UWT)、肾积水严重程度、肾周脂肪搁浅(PFS)和疼痛强度是粘连的独立危险预测因素(P P P = 0.02; P = 0.02)。有粘连组和无粘连组的估计曲线下面积分别为0.849 (95% CI, 0.742-0.832)和0.888 (95% CI, 0.829-0.833),表明该模型具有良好的预测性能。结论:UWT、PFS、肾积水严重程度、疼痛强度是结石与粘膜间粘连发生的独立危险因素。我们的预测模型表现出色,可以帮助临床医生选择最合适的手术方法。
{"title":"Risk factors and prediction model for stone mucosa adhesion before retrograde intrarenal surgery.","authors":"Hongliang Wei, Xiaowei Wang, Shuo Zheng, Zhong Li, Lei Wang, Wei Li","doi":"10.20452/wiitm.2025.17973","DOIUrl":"10.20452/wiitm.2025.17973","url":null,"abstract":"<p><strong>Introduction: </strong>Preoperative assessment of ureteral adhesions related to stones is crucial for choosing the right surgical approach.</p><p><strong>Aim: </strong>This study aimed to evaluate clinically significant factors for predicting the development of adhesions between the calculus and the mucosa in patients with ureteral stones undergoing retrograde intrarenal surgery.</p><p><strong>Materials and methods: </strong>The study included 173 patients. Ureteroscopy was performed to accurately identify the presence of adhesions between the calculus and the mucosa. Univariate and multivariable logistic regression analyses were performed to identify independent factors predicting adhesions. An alignment diagram model was developed utilizing the independent factors identified. Discrimination and calibration of the model were evaluated via the receiver operating characteristic curve and further examined via calibration curves, decision curve analysis, and cumulative intervention curves.</p><p><strong>Result: </strong>Adhesions between the calculus and the mucosa were confirmed on ureteroscopy in 48 patients (27.7%). Multivariable logistic regression analyses showed that ureteral wall thickness (UWT), hydronephrosis severity, perirenal fat stranding (PFS), and pain intensity were independent risk predictors of adhesions (<i>P</i> <⁠0.001; <i>P</i> <⁠0.001; <i>P</i> = 0.02; <i>P</i> = 0.02, respectively). The estimated area under the curve in the group with and without adhesions was 0.849 (95% CI, 0.742-0.832) and 0.888 (95% CI, 0.829-0.833), respectively, demonstrating an excellent predictive performance of the model.</p><p><strong>Conclusion: </strong>UWT, PFS, hydronephrosis severity, and pain intensity are independent risk factors for the development of adhesions between the calculus and the mucosa. Our predictive model exhibited outstanding performance, and it may help clinicians choose the most appropriate surgical method.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 3","pages":"285-294"},"PeriodicalIF":1.9,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12590371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effect of complete endoscopic thyroidectomy through different approaches on the recurrent laryngeal nerve. 内镜下不同入路甲状腺全切除术对喉返神经的保护作用。
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-24 eCollection Date: 2025-10-06 DOI: 10.20452/wiitm.2025.17965
Jianghai Li, Yuming Hua

Introduction: Papillary thyroid carcinoma (PTC) is a malignancy originating from the thyroid follicular epithelium, accounting for over 80% of thyroid cancer globally. It is often asymptomatic in its early stages, but over time, it may invade the unilateral recurrent laryngeal nerve (RLN), leading to hoarseness, weak speech, or dysphagia. In order to prevent further complications, prompt treatment is required, and surgery remains the primary and most effective option.

Aim: This study aimed to evaluate the protective effect of complete endoscopic thyroidectomy (CET) via different approaches on the RLN.

Materials and methods: The study analyzed clinical data of 100 patients with clinically node-negative PTC, who underwent CET via the breast approach from February 2023 to February 2025. The patients were divided into 2 groups: the control group (n = 55) which underwent CET via the axillary approach and the study group (n = 45), subjected to CET via the clavicular approach.

Result: Postoperative assessments showed considerable improvements in amplitude perturbation, fundamental frequency perturbation, harmonic-to-noise ratio, and normalized noise energy in both groups, with the study group demonstrating superior results (P <⁠0.05). One month after surgery, the voice handicap index score decreased in both groups, as compared with preoperative levels, the study group having obtained a lower score (P <⁠0.05). The Scar Cosmesis Assessment and Rating score increased postoperatively in both groups, with a higher score recorded in the study group (P <⁠0.05). The Short Form-36 Heath Status Questionnaire scores increased across all dimensions postoperatively in both groups, with the study group showing greater improvements (P <⁠0.05).

Conclusion: Compared with the axillary approach, CET via the clavicular approach results in greater postoperative improvements in acoustic parameters, lower voice handicap index scores, better scar appearance, and higher Short Form-36 health status scores.

简介:甲状腺乳头状癌(PTC)是一种起源于甲状腺滤泡上皮的恶性肿瘤,占全球甲状腺癌的80%以上。它在早期通常无症状,但随着时间的推移,它可能侵犯单侧喉返神经(RLN),导致声音嘶哑、言语微弱或吞咽困难。为了防止进一步的并发症,需要及时治疗,手术仍然是主要和最有效的选择。目的:本研究旨在评价内镜下甲状腺全切除术(CET)不同入路对RLN的保护作用。材料与方法:本研究分析了2023年2月至2025年2月100例临床淋巴结阴性PTC患者经乳腺入路行CET的临床资料。将患者分为两组:对照组(55例)经腋窝入路行体外循环治疗,研究组(45例)经锁骨入路行体外循环治疗。结果:术后评估显示,两组在幅度摄动、基频摄动、谐波噪声比和归一化噪声能量方面均有显著改善,其中研究组表现出较好的效果(P P P P P)。与腋窝入路相比,经锁骨入路行CET术后声学参数改善更大,声音障碍指数评分更低,疤痕外观更好,Short Form-36健康状况评分更高。
{"title":"Protective effect of complete endoscopic thyroidectomy through different approaches on the recurrent laryngeal nerve.","authors":"Jianghai Li, Yuming Hua","doi":"10.20452/wiitm.2025.17965","DOIUrl":"10.20452/wiitm.2025.17965","url":null,"abstract":"<p><strong>Introduction: </strong>Papillary thyroid carcinoma (PTC) is a malignancy originating from the thyroid follicular epithelium, accounting for over 80% of thyroid cancer globally. It is often asymptomatic in its early stages, but over time, it may invade the unilateral recurrent laryngeal nerve (RLN), leading to hoarseness, weak speech, or dysphagia. In order to prevent further complications, prompt treatment is required, and surgery remains the primary and most effective option.</p><p><strong>Aim: </strong>This study aimed to evaluate the protective effect of complete endoscopic thyroidectomy (CET) via different approaches on the RLN.</p><p><strong>Materials and methods: </strong>The study analyzed clinical data of 100 patients with clinically node-negative PTC, who underwent CET via the breast approach from February 2023 to February 2025. The patients were divided into 2 groups: the control group (n = 55) which underwent CET via the axillary approach and the study group (n = 45), subjected to CET via the clavicular approach.</p><p><strong>Result: </strong>Postoperative assessments showed considerable improvements in amplitude perturbation, fundamental frequency perturbation, harmonic-to-noise ratio, and normalized noise energy in both groups, with the study group demonstrating superior results (<i>P</i> <⁠0.05). One month after surgery, the voice handicap index score decreased in both groups, as compared with preoperative levels, the study group having obtained a lower score (<i>P</i> <⁠0.05). The Scar Cosmesis Assessment and Rating score increased postoperatively in both groups, with a higher score recorded in the study group (<i>P</i> <⁠0.05). The Short Form-36 Heath Status Questionnaire scores increased across all dimensions postoperatively in both groups, with the study group showing greater improvements (<i>P</i> <⁠0.05).</p><p><strong>Conclusion: </strong>Compared with the axillary approach, CET via the clavicular approach results in greater postoperative improvements in acoustic parameters, lower voice handicap index scores, better scar appearance, and higher Short Form-36 health status scores.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 3","pages":"266-272"},"PeriodicalIF":1.9,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12590374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Best medical treatment vs endovascular repair for uncomplicated acute type B aortic dissection: a comparative study. 无并发症急性B型主动脉夹层最佳药物治疗与血管内修复的比较研究。
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-24 eCollection Date: 2025-10-06 DOI: 10.20452/wiitm.2025.17972
Fu-Kang Yuan, Hong-Yi Yang, Yu-Fei Fu, Zhong Tian, Hua-Wei Zhuo, Ming-Bao Chen

Introduction: Both best medical treatment (BMT) and endovascular repair (ER) are viable treatment strategies in uncomplicated acute type B aortic dissection (TBAD). However, long-term outcomes of these 2 approaches remain a topic of debate.

Aim: This study was developed to compare the clinical efficacy, short-term outcomes, and long-term results of ER and BMT in the management of uncomplicated TBAD.

Materials and methods: This retrospective, single-center study included consecutive individuals diagnosed with uncomplicated TBAD who underwent ER or BMT between January 2019 and August 2024. Relative outcomes for these 2 treatment approaches were compared.

Result: In total, 165 and 148 patients who respectively received ER and BMT were enrolled in the analysis. Relative to BMT, ER significantly increased the thrombosed / obliterated false lumen rate (81.8% vs 16.2%, respectively; P = 0.001), reduced the rupture rate (1.8% vs 12.2%, respectively; P = 0.001), and decreased late mortality (4.8% vs 14.2%, respectively; P = 0.004). The rates of retrograde type A dissection, organ failure, and early mortality in the BMT and ER groups were similar (1.8% vs 3.4%; P = 0.48; 0.6% vs 2%; P = 0.35; 0.6% vs 4.1%; P = 0.06, respectively). In the ER group, the overall survival rates at 1, 3, and 5 years were 98.8%, 96.5%, and 94.6%, respectively, while the BMT group exhibited corresponding survival rates of 94.5%, 91.5%, and 84.7%.

Conclusion: In comparison with BMT, ER significantly reduces rupture rate and enhances thrombosed / obliterated false lumen rate, thereby improving long-term prognosis.

摘要:最佳药物治疗(best medical treatment, BMT)和血管内修复(endovascular repair, ER)是治疗无并发症急性B型主动脉夹层(TBAD)的可行方法。然而,这两种方法的长期效果仍然是一个有争议的话题。目的:本研究旨在比较ER和BMT治疗非复杂性TBAD的临床疗效、短期结果和长期结果。材料和方法:这项回顾性单中心研究纳入了2019年1月至2024年8月期间连续接受ER或BMT治疗的诊断为非复杂性TBAD的个体。比较两种治疗方法的相对结果。结果:共有165例和148例分别接受ER和BMT的患者纳入分析。与BMT相比,ER显著增加了血栓形成/闭塞的假腔率(分别为81.8%和16.2%,P = 0.001),降低了破裂率(分别为1.8%和12.2%,P = 0.001),降低了晚期死亡率(分别为4.8%和14.2%,P = 0.004)。BMT组和ER组逆行性A型夹层、器官衰竭和早期死亡率相似(分别为1.8% vs 3.4%; P = 0.48; 0.6% vs 2%; P = 0.35; 0.6% vs 4.1%; P = 0.06)。ER组1、3、5年总生存率分别为98.8%、96.5%、94.6%,BMT组相应生存率为94.5%、91.5%、84.7%。结论:与BMT相比,ER可显著降低血管破裂率,提高血栓形成/闭塞假腔率,从而改善长期预后。
{"title":"Best medical treatment vs endovascular repair for uncomplicated acute type B aortic dissection: a comparative study.","authors":"Fu-Kang Yuan, Hong-Yi Yang, Yu-Fei Fu, Zhong Tian, Hua-Wei Zhuo, Ming-Bao Chen","doi":"10.20452/wiitm.2025.17972","DOIUrl":"10.20452/wiitm.2025.17972","url":null,"abstract":"<p><strong>Introduction: </strong>Both best medical treatment (BMT) and endovascular repair (ER) are viable treatment strategies in uncomplicated acute type B aortic dissection (TBAD). However, long-term outcomes of these 2 approaches remain a topic of debate.</p><p><strong>Aim: </strong>This study was developed to compare the clinical efficacy, short-term outcomes, and long-term results of ER and BMT in the management of uncomplicated TBAD.</p><p><strong>Materials and methods: </strong>This retrospective, single-center study included consecutive individuals diagnosed with uncomplicated TBAD who underwent ER or BMT between January 2019 and August 2024. Relative outcomes for these 2 treatment approaches were compared.</p><p><strong>Result: </strong>In total, 165 and 148 patients who respectively received ER and BMT were enrolled in the analysis. Relative to BMT, ER significantly increased the thrombosed / obliterated false lumen rate (81.8% vs 16.2%, respectively; <i>P</i> = 0.001), reduced the rupture rate (1.8% vs 12.2%, respectively; <i>P</i> = 0.001), and decreased late mortality (4.8% vs 14.2%, respectively; <i>P</i> = 0.004). The rates of retrograde type A dissection, organ failure, and early mortality in the BMT and ER groups were similar (1.8% vs 3.4%; <i>P</i> = 0.48; 0.6% vs 2%; <i>P</i> = 0.35; 0.6% vs 4.1%; <i>P</i> = 0.06, respectively). In the ER group, the overall survival rates at 1, 3, and 5 years were 98.8%, 96.5%, and 94.6%, respectively, while the BMT group exhibited corresponding survival rates of 94.5%, 91.5%, and 84.7%.</p><p><strong>Conclusion: </strong>In comparison with BMT, ER significantly reduces rupture rate and enhances thrombosed / obliterated false lumen rate, thereby improving long-term prognosis.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 3","pages":"331-335"},"PeriodicalIF":1.9,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12590380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative decompression for left-sided obstructive colorectal cancer: a comparative study between a stent and a decompression tube. 左侧梗阻性结直肠癌术前减压:支架与减压管的比较研究。
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-04 eCollection Date: 2025-07-08 DOI: 10.20452/wiitm.2025.17956
Xin-Chun Guo, Qiang Lu, Yu-Fei Fu, Xin Lu

Introduction: Stents and decompression tubes (DTs) are both commonly utilized for preoperative decompression in patients with left-sided obstructive colorectal cancer (OCRC). However, the comparative effectiveness and oncological safety of these 2 approaches remain uncertain.

Aim: The aim of this study was to compare clinical performance and long-term oncological outcomes of preoperative stent and DT insertion in patients with left-sided OCRC.

Materials and methods: The study included 87 consecutive patients, diagnosed with left-sided OCRC between January 2022 and December 2024. All patients underwent preoperative decompression using either a stent or a DT. Clinical decompression efficacy, surgical outcomes, and oncological parameters were compared between the groups.

Results: Among the 87 patients enrolled, 45 received a stent and 42, a DT. Technical success rates were similar between the groups (stent, 95.6% vs DT, 97.6%; P >0.99), as were clinical success rates (stent, 88.9% vs DT, 90.5%; P >0.99). Perforation occurred in 3 patients (6.7%) in the stent group and 1 participant (2.4%) in the DT group (P = 0.62). Primary anastomosis was achieved in 84.4% of the stent patients and 81% of the DT patients (P = 0.67). Median disease-free survival was 32 (21-43) months in the stent group and 34 (25-43) months in the DT group (P = 0.35), while median overall survival was 38 (29-47) and 39 (34-44) months, respectively (P = 0.53), with no apparent differences between the groups.

Conclusions: Both stent and DT insertion are safe and effective strategies for preoperative left-sided OCRC management. No significant differences in either short-term clinical outcomes or long-term oncological results were observed between the 2 methods.

导语:支架和减压管(DTs)都是左侧梗阻性结直肠癌(OCRC)患者术前常用的减压方法。然而,这两种方法的相对有效性和肿瘤安全性仍然不确定。目的:本研究的目的是比较左侧OCRC患者术前支架置入和DT置入的临床表现和长期肿瘤预后。材料和方法:该研究纳入了2022年1月至2024年12月诊断为左侧OCRC的87例连续患者。所有患者术前均行支架或DT减压。比较两组患者的临床减压效果、手术结果及肿瘤参数。结果:87例入组患者中,45例接受支架植入,42例接受DT植入。两组间技术成功率相似(支架,95.6% vs DT, 97.6%;P < 0.99),临床成功率(支架,88.9% vs DT, 90.5%;P > 0.99)。支架组出现穿孔3例(6.7%),DT组出现穿孔1例(2.4%)(P = 0.62)。支架组和DT组一期吻合率分别为84.4%和81% (P = 0.67)。支架组中位无病生存期为32(21-43)个月,DT组中位无病生存期为34(25-43)个月(P = 0.35),总生存期中位分别为38(29-47)个月和39(34-44)个月(P = 0.53),两组间无明显差异。结论:支架植入和DT植入是术前治疗左侧OCRC安全有效的策略。两种方法的短期临床结果和长期肿瘤学结果均无显著差异。
{"title":"Preoperative decompression for left-sided obstructive colorectal cancer: a comparative study between a stent and a decompression tube.","authors":"Xin-Chun Guo, Qiang Lu, Yu-Fei Fu, Xin Lu","doi":"10.20452/wiitm.2025.17956","DOIUrl":"10.20452/wiitm.2025.17956","url":null,"abstract":"<p><strong>Introduction: </strong>Stents and decompression tubes (DTs) are both commonly utilized for preoperative decompression in patients with left-sided obstructive colorectal cancer (OCRC). However, the comparative effectiveness and oncological safety of these 2 approaches remain uncertain.</p><p><strong>Aim: </strong>The aim of this study was to compare clinical performance and long-term oncological outcomes of preoperative stent and DT insertion in patients with left-sided OCRC.</p><p><strong>Materials and methods: </strong>The study included 87 consecutive patients, diagnosed with left-sided OCRC between January 2022 and December 2024. All patients underwent preoperative decompression using either a stent or a DT. Clinical decompression efficacy, surgical outcomes, and oncological parameters were compared between the groups.</p><p><strong>Results: </strong>Among the 87 patients enrolled, 45 received a stent and 42, a DT. Technical success rates were similar between the groups (stent, 95.6% vs DT, 97.6%; P >0.99), as were clinical success rates (stent, 88.9% vs DT, 90.5%; P >0.99). Perforation occurred in 3 patients (6.7%) in the stent group and 1 participant (2.4%) in the DT group (P = 0.62). Primary anastomosis was achieved in 84.4% of the stent patients and 81% of the DT patients (P = 0.67). Median disease-free survival was 32 (21-43) months in the stent group and 34 (25-43) months in the DT group (P = 0.35), while median overall survival was 38 (29-47) and 39 (34-44) months, respectively (P = 0.53), with no apparent differences between the groups.</p><p><strong>Conclusions: </strong>Both stent and DT insertion are safe and effective strategies for preoperative left-sided OCRC management. No significant differences in either short-term clinical outcomes or long-term oncological results were observed between the 2 methods.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 2","pages":"172-176"},"PeriodicalIF":1.9,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329667/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safe and effective antireflux surgery in lung transplant recipients: preliminary results. 肺移植受者安全有效的抗反流手术:初步结果
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-04 eCollection Date: 2025-07-08 DOI: 10.20452/wiitm.2025.17963
Maciej Wiewiora, Marek Ochman, Maciej Urlik, Katarzyna Hajduk, Aleksandra Gil, Konrad Karcz, Tomasz Hrapkowicz

Introduction: Obliterative bronchiolitis, the clinical manifestation of bronchiolitis obliterans syndrome (BOS), is a major complication of lung transplantation and one of the primary causes of chronic lung allograft dysfunction leading to poor survival outcomes.

Aim: The aim of this study was to evaluate the safety and outcomes of antireflux surgery in lung transplant recipients (LTRs) with BOS and associated gastroesophageal reflux disease (GERD).

Materials and methods: This single-center study included 8 consecutive patients at a median (interquartile range [IQR]) age of 29 (25-46) years who underwent bilateral lung transplantation and subsequent antireflux surgery due to BOS. The decision to proceed with laparoscopic surgery was based on a diagnosis of GERD associated with a decline in pulmonary function, confirmed on bronchoscopy indicative of BOS. Follow-up lasted for 12 months.

Results: Median (IQR) time since transplantation was 27 (15-55.5) months. Significant improvements in spirometric parameters were observed at 3 and 12 months postoperatively, as compared with baseline, including forced expiratory volume in 1 second (FEV1; P = 0.02), FEV1% predicted (P = 0.02), forced vital capacity (FVC; P = 0.003), and FVC% predicted (P = 0.02). There were no differences in spirometric parameters between 3 and 12 months postoperatively. No surgical complications were observed within 30 days after surgery or during follow-up. Two patients developed pulmonary complications, and 1 patient with a history of kidney transplantation experienced renal complications. There were no postoperative deaths. Median (IQR) hospital stay was 12 (3-29) days.

Conclusions: The study suggests that antireflux surgery in LTRs is a safe and effective approach for GERD management, while improving lung function with minimal adverse effects.

简介:闭塞性细支气管炎,临床表现为闭塞性细支气管炎综合征(BOS),是肺移植的主要并发症之一,也是慢性同种异体肺移植功能障碍导致生存预后差的主要原因之一。目的:本研究的目的是评估肺移植受者(LTRs)患有BOS和相关胃食管反流病(GERD)的抗反流手术的安全性和结果。材料和方法:本单中心研究纳入8例连续患者,中位年龄(四分位间距[IQR])为29岁(25-46岁),均因BOS行双侧肺移植和随后的抗反流手术。进行腹腔镜手术的决定是基于与肺功能下降相关的GERD诊断,经支气管镜检查证实为BOS。随访12个月。结果:移植后中位(IQR)时间为27(15-55.5)个月。与基线相比,术后3个月和12个月的肺活量测量参数有显著改善,包括1秒用力呼气量(FEV1;P = 0.02),预测FEV1% (P = 0.02),用力肺活量(FVC;P = 0.003), FVC%预测(P = 0.02)。术后3个月和12个月肺活量指标无差异。术后30天及随访期间均未见手术并发症。2例出现肺部并发症,1例有肾移植史的患者出现肾脏并发症。无术后死亡病例。中位(IQR)住院时间为12(3-29)天。结论:本研究提示ltr的抗反流手术是一种安全有效的治疗GERD的方法,同时改善肺功能,不良反应最小。
{"title":"Safe and effective antireflux surgery in lung transplant recipients: preliminary results.","authors":"Maciej Wiewiora, Marek Ochman, Maciej Urlik, Katarzyna Hajduk, Aleksandra Gil, Konrad Karcz, Tomasz Hrapkowicz","doi":"10.20452/wiitm.2025.17963","DOIUrl":"10.20452/wiitm.2025.17963","url":null,"abstract":"<p><strong>Introduction: </strong>Obliterative bronchiolitis, the clinical manifestation of bronchiolitis obliterans syndrome (BOS), is a major complication of lung transplantation and one of the primary causes of chronic lung allograft dysfunction leading to poor survival outcomes.</p><p><strong>Aim: </strong>The aim of this study was to evaluate the safety and outcomes of antireflux surgery in lung transplant recipients (LTRs) with BOS and associated gastroesophageal reflux disease (GERD).</p><p><strong>Materials and methods: </strong>This single-center study included 8 consecutive patients at a median (interquartile range [IQR]) age of 29 (25-46) years who underwent bilateral lung transplantation and subsequent antireflux surgery due to BOS. The decision to proceed with laparoscopic surgery was based on a diagnosis of GERD associated with a decline in pulmonary function, confirmed on bronchoscopy indicative of BOS. Follow-up lasted for 12 months.</p><p><strong>Results: </strong>Median (IQR) time since transplantation was 27 (15-55.5) months. Significant improvements in spirometric parameters were observed at 3 and 12 months postoperatively, as compared with baseline, including forced expiratory volume in 1 second (FEV<sub>1</sub>; <i>P</i> = 0.02), FEV<sub>1</sub>% predicted (<i>P</i> = 0.02), forced vital capacity (FVC; <i>P</i> = 0.003), and FVC% predicted (<i>P</i> = 0.02). There were no differences in spirometric parameters between 3 and 12 months postoperatively. No surgical complications were observed within 30 days after surgery or during follow-up. Two patients developed pulmonary complications, and 1 patient with a history of kidney transplantation experienced renal complications. There were no postoperative deaths. Median (IQR) hospital stay was 12 (3-29) days.</p><p><strong>Conclusions: </strong>The study suggests that antireflux surgery in LTRs is a safe and effective approach for GERD management, while improving lung function with minimal adverse effects.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 2","pages":"184-189"},"PeriodicalIF":1.9,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of different perioperative dexmedetomidine administration regimens on postoperative sleep quality in gastrointestinal tumor resection: a randomized controlled trial. 不同围手术期右美托咪定给药方案对胃肠道肿瘤切除术术后睡眠质量的影响:一项随机对照试验。
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-04 eCollection Date: 2025-07-08 DOI: 10.20452/wiitm.2025.17966
Chengying Ji, Xiaodong Su, Chaohui Gao, Qijing Liu, Ying Liu, Qian Fu, Boxiong Gao, Jiayi Xie, Bokang Yang, Jinxiang Xie, Huping Song, Yatao Liu

Introduction: Perioperative sleep disorders constitute a recognized risk factor for multiple postoperative complications. Although dexmedetomidine (DEX) has been clinically employed to enhance perioperative sleep quality, its optimal administration protocol for postoperative sleep improvement remains undetermined.

Aim: The aim of this study was to comparatively evaluate the therapeutic effect of distinct perioperative DEX administration strategies on postoperative sleep quality in patients undergoing elective gastrointestinal tumor resection via laparoscopy.

Materials and methods: A total of 48 patients undergoing laparoscopic gastrointestinal resection between September 2024 and January 2025 were enrolled and randomly allocated to the intraoperative continuous DEX infusion group (group I; n = 24) and the group with DEX added to postoperative intravenous analgesia (group P; n = 24) using a double-blind method. Sleep quality was assessed using the Numerical Rating Scale during the first 3 postoperative days. A comparative analysis of intergroup differences in postoperative sleep quality was performed.

Results: Out of the 48 randomized participants, 47 were included in the analysis, as 1 patient from group P withdrew informed consent postoperatively. Baseline data were balanced between the 2 groups. In comparison with group I, on postoperative day 1, group P exhibited considerably higher sleep quality scores (P = 0.045), lower blood glucose levels at skin suture completion (P <⁠0.001), higher intraoperative norepinephrine doses (P <⁠0.001), and reduced intraoperative blood loss (P = 0.03). Multivariable linear regression identified group assignment (P = 0.03) and sex (P = 0.02) as significant predictors of sleep quality on postoperative day 1.

Conclusions: As compared with intraoperative continuous DEX infusion, addition of DEX to postoperative analgesia in laparoscopic gastrointestinal tumor surgery has better outcomes with regard to sleep quality on postoperative day 1. These findings suggest potential advantages of postoperative DEX administration in perioperative management.

围手术期睡眠障碍是多种术后并发症公认的危险因素。虽然右美托咪定(DEX)已在临床上用于改善围手术期睡眠质量,但其改善术后睡眠的最佳给药方案仍未确定。目的:本研究的目的是比较评价不同围手术期给药策略对腹腔镜择期胃肠道肿瘤切除术患者术后睡眠质量的影响。材料与方法:入选2024年9月至2025年1月行腹腔镜胃肠道切除术的患者48例,随机分为术中持续输注DEX组(I组;n = 24)和术后静脉镇痛加DEX组(P组;N = 24),采用双盲法。术后前3天采用数值评定量表评估睡眠质量。对比分析两组患者术后睡眠质量差异。结果:48例随机受试者中,47例纳入分析,P组1例患者术后撤回知情同意。两组间基线数据平衡。与I组相比,术后第1天,P组睡眠质量评分明显较高(P = 0.045),皮肤缝合完成时血糖水平较低(P P P = 0.03)。多变量线性回归发现分组分配(P = 0.03)和性别(P = 0.02)是术后第1天睡眠质量的重要预测因素。结论:与术中持续输注DEX相比,在腹腔镜胃肠道肿瘤手术术后镇痛中加入DEX在术后第1天的睡眠质量方面具有更好的效果。这些发现提示了术后给药DEX在围手术期管理中的潜在优势。
{"title":"Impact of different perioperative dexmedetomidine administration regimens on postoperative sleep quality in gastrointestinal tumor resection: a randomized controlled trial.","authors":"Chengying Ji, Xiaodong Su, Chaohui Gao, Qijing Liu, Ying Liu, Qian Fu, Boxiong Gao, Jiayi Xie, Bokang Yang, Jinxiang Xie, Huping Song, Yatao Liu","doi":"10.20452/wiitm.2025.17966","DOIUrl":"10.20452/wiitm.2025.17966","url":null,"abstract":"<p><strong>Introduction: </strong>Perioperative sleep disorders constitute a recognized risk factor for multiple postoperative complications. Although dexmedetomidine (DEX) has been clinically employed to enhance perioperative sleep quality, its optimal administration protocol for postoperative sleep improvement remains undetermined.</p><p><strong>Aim: </strong>The aim of this study was to comparatively evaluate the therapeutic effect of distinct perioperative DEX administration strategies on postoperative sleep quality in patients undergoing elective gastrointestinal tumor resection via laparoscopy.</p><p><strong>Materials and methods: </strong>A total of 48 patients undergoing laparoscopic gastrointestinal resection between September 2024 and January 2025 were enrolled and randomly allocated to the intraoperative continuous DEX infusion group (group I; n = 24) and the group with DEX added to postoperative intravenous analgesia (group P; n = 24) using a double-blind method. Sleep quality was assessed using the Numerical Rating Scale during the first 3 postoperative days. A comparative analysis of intergroup differences in postoperative sleep quality was performed.</p><p><strong>Results: </strong>Out of the 48 randomized participants, 47 were included in the analysis, as 1 patient from group P withdrew informed consent postoperatively. Baseline data were balanced between the 2 groups. In comparison with group I, on postoperative day 1, group P exhibited considerably higher sleep quality scores (<i>P</i> = 0.045), lower blood glucose levels at skin suture completion (<i>P</i> <⁠0.001), higher intraoperative norepinephrine doses (<i>P</i> <⁠0.001), and reduced intraoperative blood loss (<i>P</i> = 0.03). Multivariable linear regression identified group assignment (<i>P</i> = 0.03) and sex (<i>P</i> = 0.02) as significant predictors of sleep quality on postoperative day 1.</p><p><strong>Conclusions: </strong>As compared with intraoperative continuous DEX infusion, addition of DEX to postoperative analgesia in laparoscopic gastrointestinal tumor surgery has better outcomes with regard to sleep quality on postoperative day 1. These findings suggest potential advantages of postoperative DEX administration in perioperative management.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 2","pages":"157-164"},"PeriodicalIF":1.9,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of probiotics on glycemic control during the first 3 months after sleeve gastrectomy: a prospective placebo‑controlled study. 益生菌对袖式胃切除术后前3个月血糖控制的影响:一项前瞻性安慰剂对照研究
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-04 eCollection Date: 2025-07-08 DOI: 10.20452/wiitm.2025.17968
Dominika Mysiorska, Natalia Mazek, Julia Młyńska, Ewelina Sosnowska-Turek, Paweł Lech, Natalia Dowgiałło-Gornowicz

Introduction: Sleeve gastrectomy (SG) is a safe metabolic and bariatric surgery but it often leads to postoperative gastrointestinal issues, such as constipation and bloating. The use of probiotics after SG seems to alleviate these symptoms.

Aim: The aim of this study was to assess the impact of probiotic supplementation on macro- and micronutrient levels, specifically glycated hemoglobin (HbA1c), 3 months after SG. The secondary objective was to analyze the effect of probiotics on gastrointestinal symptoms.

Materials and methods: This was a prospective, placebo-controlled study which included patients undergoing SG at a single center in Poland. Before the surgery, the patients did not note gastrointestinal diseases or symptoms. They were randomly assigned to the probiotics group (PG) or the control group (CG). Gastrointestinal symptoms and laboratory test results were assessed before surgery and 3 months postoperatively.

Results: A total of 24 patients were included in the study, of which 11 were assigned to the PG and 13, to the CG. Three months after surgery, the patients in the PG had slightly lower levels of HbA1c than the CG participants (P = 0.01). The patients in the PG reported less constipation, better feeling of bowel movement completeness, and greater ease of defecation (P = 0.03; P = 0.01; P = 0.01, respectively) No differences in weight loss were found between the groups.

Conclusions: Probiotics may lower HbA1c levels, effectively reduce constipation, contribute to a better feeling of bowel movement, and facilitate defecation after SG.

简介:袖式胃切除术(SG)是一种安全的代谢和减肥手术,但它经常导致术后胃肠道问题,如便秘和腹胀。SG术后使用益生菌似乎可以缓解这些症状。目的:本研究的目的是评估益生菌补充对SG后3个月宏量和微量营养素水平的影响,特别是糖化血红蛋白(HbA1c)。次要目的是分析益生菌对胃肠道症状的影响。材料和方法:这是一项前瞻性,安慰剂对照研究,包括在波兰单一中心接受SG的患者。手术前,患者没有胃肠道疾病或症状。他们被随机分为益生菌组(PG)和对照组(CG)。术前和术后3个月评估胃肠道症状和实验室检查结果。结果:共纳入24例患者,其中PG组11例,CG组13例。术后3个月,PG组患者的HbA1c水平略低于CG组(P = 0.01)。PG组患者便秘较少,排便完整感更好,排便更容易(P = 0.03;P = 0.01;P = 0.01)各组体重减轻无显著差异。结论:益生菌可降低糖化血红蛋白水平,有效减少便秘,有助于改善排便感,促进SG后的排便。
{"title":"The impact of probiotics on glycemic control during the first 3 months after sleeve gastrectomy: a prospective placebo‑controlled study.","authors":"Dominika Mysiorska, Natalia Mazek, Julia Młyńska, Ewelina Sosnowska-Turek, Paweł Lech, Natalia Dowgiałło-Gornowicz","doi":"10.20452/wiitm.2025.17968","DOIUrl":"10.20452/wiitm.2025.17968","url":null,"abstract":"<p><strong>Introduction: </strong>Sleeve gastrectomy (SG) is a safe metabolic and bariatric surgery but it often leads to postoperative gastrointestinal issues, such as constipation and bloating. The use of probiotics after SG seems to alleviate these symptoms.</p><p><strong>Aim: </strong>The aim of this study was to assess the impact of probiotic supplementation on macro- and micronutrient levels, specifically glycated hemoglobin (HbA1c), 3 months after SG. The secondary objective was to analyze the effect of probiotics on gastrointestinal symptoms.</p><p><strong>Materials and methods: </strong>This was a prospective, placebo-controlled study which included patients undergoing SG at a single center in Poland. Before the surgery, the patients did not note gastrointestinal diseases or symptoms. They were randomly assigned to the probiotics group (PG) or the control group (CG). Gastrointestinal symptoms and laboratory test results were assessed before surgery and 3 months postoperatively.</p><p><strong>Results: </strong>A total of 24 patients were included in the study, of which 11 were assigned to the PG and 13, to the CG. Three months after surgery, the patients in the PG had slightly lower levels of HbA<sub>1c</sub> than the CG participants (<i>P</i> = 0.01). The patients in the PG reported less constipation, better feeling of bowel movement completeness, and greater ease of defecation (<i>P</i> = 0.03; <i>P</i> = 0.01; <i>P</i> = 0.01, respectively) No differences in weight loss were found between the groups.</p><p><strong>Conclusions: </strong>Probiotics may lower HbA1c levels, effectively reduce constipation, contribute to a better feeling of bowel movement, and facilitate defecation after SG.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 2","pages":"190-195"},"PeriodicalIF":1.9,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329665/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allogeneic fibroblasts vs conventional debridement after successful endovascular interventions for treating chronic ulcers induced by peripheral artery disease. 同种异体成纤维细胞与血管内介入治疗外周动脉疾病引起的慢性溃疡后的传统清创比较
IF 1.9 4区 医学 Q2 SURGERY Pub Date : 2025-07-04 eCollection Date: 2025-07-08 DOI: 10.20452/wiitm.2025.17959
Azat Chinaliyev, Azat Chinaliyev, Bazylbek Zhakiyev, Didar Khassenov, Gulnara Sakhipova, Natalya Zagorulya, Gaukhar Kuanyshbayeva, Nurlan Zhampeissov, Damir Biktashev, Murat Jakanov, Ainur Donayeva, Ibrahim A Abdelazim

Introduction: Fibroblasts are stromal and connective tissue cells that play crucial roles in the intracellular matrix and granulation tissue synthesis during tissue proliferation. They are also responsible for epithelialization and healing of skin lesions.

Aim: Our aim was to compare the use of allogeneic fibroblasts with conventional debridement after successful endovascular interventions (EVIs) for the treatment of chronic ulcers induced by peripheral artery disease (PAD).

Materials and methods: A total of 116 participants with chronic ulcers due to PAD were randomly assigned, after successful EVI, to receive either allogeneic fibroblasts (study group; n = 58) or conventional debridement (control group; n = 58) for treatment of the ulcers. The participant data were collected over 1 year of follow-up to compare the effectiveness of both methods.

Results: The mean (SD) duration of initial and complete healing of chronic ulcers after successful EVI was shorter in the allogeneic fibroblast group (2.59 [0.53] and 5.04 [0.58] months, respectively) than in the controls (3.56 [0.44] and 5.8 [0.35] months, respectively; P <⁠0.001 for all). A correlation analysis showed a moderately significant correlation between the healing of chronic ulcers (both initial and complete) after successful EVI and the use of allogeneic fibroblasts.

Conclusions: Allogeneic fibroblasts are an effective and noninvasive option for the treatment of chronic PAD-induced ulcers after successful EVI. The duration of initial and complete healing was significantly shorter in the allogeneic fibroblast group than in the conventional debridement group.

成纤维细胞是间质细胞和结缔组织细胞,在组织增殖过程中对细胞内基质和肉芽组织的合成起着至关重要的作用。它们也负责皮肤损伤的上皮化和愈合。目的:我们的目的是比较同种异体成纤维细胞与血管内干预(EVIs)成功治疗外周动脉疾病(PAD)引起的慢性溃疡后的常规清创的应用。材料和方法:共有116名因PAD引起的慢性溃疡患者被随机分配,在EVI成功后接受同种异体成纤维细胞(研究组;N = 58)或常规清创(对照组;N = 58)用于治疗溃疡。参与者的数据收集超过1年的随访比较两种方法的有效性。结果:同种异体成纤维细胞组成功EVI后慢性溃疡初始愈合和完全愈合的平均(SD)时间(分别为2.59[0.53]和5.04[0.58]个月)短于对照组(分别为3.56[0.44]和5.8[0.35]个月;结论:同种异体成纤维细胞是治疗EVI成功后慢性pad诱导溃疡的有效且无创的选择。同种异体成纤维细胞组的初始愈合和完全愈合时间明显短于常规清创组。
{"title":"Allogeneic fibroblasts vs conventional debridement after successful endovascular interventions for treating chronic ulcers induced by peripheral artery disease.","authors":"Azat Chinaliyev, Azat Chinaliyev, Bazylbek Zhakiyev, Didar Khassenov, Gulnara Sakhipova, Natalya Zagorulya, Gaukhar Kuanyshbayeva, Nurlan Zhampeissov, Damir Biktashev, Murat Jakanov, Ainur Donayeva, Ibrahim A Abdelazim","doi":"10.20452/wiitm.2025.17959","DOIUrl":"10.20452/wiitm.2025.17959","url":null,"abstract":"<p><strong>Introduction: </strong>Fibroblasts are stromal and connective tissue cells that play crucial roles in the intracellular matrix and granulation tissue synthesis during tissue proliferation. They are also responsible for epithelialization and healing of skin lesions.</p><p><strong>Aim: </strong>Our aim was to compare the use of allogeneic fibroblasts with conventional debridement after successful endovascular interventions (EVIs) for the treatment of chronic ulcers induced by peripheral artery disease (PAD).</p><p><strong>Materials and methods: </strong>A total of 116 participants with chronic ulcers due to PAD were randomly assigned, after successful EVI, to receive either allogeneic fibroblasts (study group; n = 58) or conventional debridement (control group; n = 58) for treatment of the ulcers. The participant data were collected over 1 year of follow-up to compare the effectiveness of both methods.</p><p><strong>Results: </strong>The mean (SD) duration of initial and complete healing of chronic ulcers after successful EVI was shorter in the allogeneic fibroblast group (2.59 [0.53] and 5.04 [0.58] months, respectively) than in the controls (3.56 [0.44] and 5.8 [0.35] months, respectively; <i>P</i> <⁠0.001 for all). A correlation analysis showed a moderately significant correlation between the healing of chronic ulcers (both initial and complete) after successful EVI and the use of allogeneic fibroblasts.</p><p><strong>Conclusions: </strong>Allogeneic fibroblasts are an effective and noninvasive option for the treatment of chronic PAD-induced ulcers after successful EVI. The duration of initial and complete healing was significantly shorter in the allogeneic fibroblast group than in the conventional debridement group.</p>","PeriodicalId":49361,"journal":{"name":"Videosurgery and Other Miniinvasive Techniques","volume":"20 2","pages":"226-234"},"PeriodicalIF":1.9,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Videosurgery and Other Miniinvasive Techniques
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1